Samsung Biologics signed a 92.7 billion won CMO contract with MSD

Samsung Biologics signed a 92.7 billion won CMO contract with MSD: COMPANY / Reporter Kim Jisun / 2024-03-13 03:58:11

Samsung Biologics. (Photo = Samsung Biologics)

[Alpha Biz=(Chicago) Reporter Kim Jisun] Samsung BioLogics said in a public announcement on the 12th that it has signed a KRW 92.7 billion consignment production contract with global pharmaceutical company MSD Switzerland. This is equivalent to 3.09% of sales as of 2022.

The contract period can be changed according to the agreement between the two companies until December 31, 2032.

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

Paris Croissant Issues Voluntary Recall of “Dried Persimmon Pound Cake” Due to Allergen Labeling Omissio
Hyundai Motor Group Restores Vehicle Control Apps After 10-Hour Outage
HMM Completes Share Buyback Worth KRW 2.14 Trillion
Gyeonggi Police Arrest Two Chinese Nationals Over KT Mobile Payment Hacking Scheme
Financial Services Commission Imposes ₩3.66 Billion in Fines on STX and STX Marine Service for Accounting Violations Related to Overseas Litigation

뉴스댓글 >

Alphabiz - Samsung Biologics signed a 92.7 billion won CMO contract with MSD

Samsung Biologics signed a 92.7 billion won CMO contract with MSD

주요기사

많이 본 기사

인사이드

PHOTO

SNS